In the UK, a government proposal has been laid out for a national clinical trial that will offer puberty blockers to “transgender” children as young as ten. This latest foray into progressive policymaking has caused uproar in Catholic and secular circles alike, and so it should.
The idea of suppressing puberty in children barely old enough to write their own names ought to trouble anyone with even a passing interest in child welfare. It signals a willingness to push ahead with an idea repeatedly questioned by doctors, parents and, most notably, the Cass Review.
